Canada markets open in 2 hours 17 minutes

Roper Technologies, Inc. (ROP)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
540.41+2.40 (+0.45%)
At close: 04:00PM EDT
540.00 -0.41 (-0.08%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close538.01
Open537.05
Bid539.62 x 200
Ask540.72 x 100
Day's Range533.94 - 543.11
52 Week Range441.06 - 565.00
Volume552,492
Avg. Volume512,185
Market Cap57.836B
Beta (5Y Monthly)0.99
PE Ratio (TTM)42.39
EPS (TTM)12.75
Earnings DateApr 26, 2024
Forward Dividend & Yield3.00 (0.56%)
Ex-Dividend DateApr 04, 2024
1y Target Est601.97
  • GlobeNewswire

    Roper Technologies announces first quarter financial results

    Increasing full year guidanceSARASOTA, Fla., April 26, 2024 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) reported financial results for the first quarter ended March 31, 2024. The results in this press release are presented on a continuing operations basis. First quarter 2024 highlights Revenue increased 14% to $1.68 billion; organic revenue increased 8%GAAP DEPS increased 33% to $3.54; adjusted DEPS increased 13% to $4.41GAAP net earnings increased 34% to $382 millionAdjusted EBIT

  • Business Wire

    iPipeline Hires Technology Industry Veteran Adam Boone as New CFO to Accelerate Strategic Growth

    EXTON, Pa., April 25, 2024--iPipeline®, a leading provider of digital solutions for the life insurance and wealth management industries, today announces the appointment of Adam Boone as Chief Financial Officer, who will lead the financial management activities for the growing global business. Boone will play a critical role in advancing the company’s strategic operating initiatives, including spearheading plans for sustained financial growth.

  • Zacks

    Roper (ROP) Gears Up to Post Q1 Earnings: What to Expect?

    Roper's (ROP) first-quarter earnings are expected to have benefited from the robust performances of the Application Software, Network Software and Tech-enabled Products segments.